Lead generation and lead optimisation approaches in the discovery of selective, non-peptide ORL-1 receptor agonists and antagonists

Author： Ronzoni S.   Peretto I.   Giardina G.A.  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.11, Iss.4, 2001-04, pp. : 525-546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances towards the discovery of ORL-1 receptor agonists and antagonists

By Bignan Gilles C   Connolly Peter J   Middleton Steven A  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 357-388

Informa Healthcare

Access to resources Recommend Favorite

Non-peptide Antagonists and Agonists of the Bradykinin B2 Receptor

By  

Current Medicinal Chemistry, Vol. 9, Iss. 9, 2002-05 ,pp. : 913-928

Bentham Science Publishers

Access to resources Recommend Favorite

Recent discovery and development of non-peptide vasopressin V2 receptor agonists

By Kondo Kazumi  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 8, 2002-08 ,pp. : 1249-1258

Informa Healthcare

Access to resources Recommend Favorite

Non-peptide &dgr; opioid agonists and antagonists

By Dondio G.   Ronzoni S.   Petrillo P.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1075-1098

Informa Healthcare

Access to resources Recommend Favorite

Non-peptide &dgr; opioid agonists and antagonists (Part II)

By Dondio G.   Ronzoni S.   Petrillo P.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 4, 1999-04 ,pp. : 353-374

Informa Healthcare

Access to resources Recommend Favorite